Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Multimodal AI for Biomarker and Etiological Assessment of Dementias
0
Zitationen
1
Autoren
2025
Jahr
Abstract
Abstract Dementia differential diagnosis and biomarker assessment pose significant challenges due to symptom overlap and limited access to advanced imaging like PET for detecting amyloid beta (Aβ) and tau (τ) in neurodegenerative conditions such as Alzheimer’s disease (AD). In this talk, I will highlight our lab’s recent work on multimodal AI frameworks that fuse diverse data to identify dementia etiologies, handle mixed dementias and incomplete cases, and estimate Aβ/τ PET status. This approach promises scalable screening for personalized dementia management, AD therapies, and clinical trials.
Ähnliche Arbeiten
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
1989 · 33.712 Zit.
Clinical diagnosis of Alzheimer's disease
1984 · 27.898 Zit.
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 · 24.586 Zit.
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 · 20.643 Zit.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 · 18.515 Zit.